Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc." Results 141 - 160 of 202
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Aug 2010, 11:34 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), in which the Court instructed district courts to function as gatekeepers and permit only reliable and relevant expert testimony to be presented to the jury. [read post]
11 May 2020, 1:09 am by Schachtman
That was the tradition that stood in active need of reform when Daubert was decided in 1993. [read post]
3 Jan 2015, 3:47 pm by Robert Kreisman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) and granted BNSF’s motion for summary judgment. [read post]
19 Sep 2008, 8:13 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
4 Jul 2010, 4:16 pm
Merrell Dow Pharmaceuticals, Inc., 509 US 579 which, in federal courts, displaced the Frye general acceptance standard based upon the Federal Rules of Evidence. [read post]
5 Jun 2013, 5:29 am by Schachtman
Oct. 24, 1996) Merrell Dow Pharms., Inc. v. [read post]
13 Jul 2019, 8:53 am by Schachtman
Merrell Dow Pharms., Inc., 509 U.S. 579, 595 (1993). [8]  Bench Book at 10. [9]  Id. at 10. [10]  Id. at 10. [11] See State Justice Institute Act of 1984 (42 U.S.C. ch. 113, 42 U.S.C. [read post]